Lilly Medical US

Lilly's official US support channel for Medical News, Information, and Education.

[Lilly Medical US @LillyMedical]

Explore the various ways to “Ask Lilly.” This includes https://t.co/qgIViGQ6No, our website for healthcare professionals that shares our scientific presentations, publications, and educational materials. We’re here to help!

[Lilly Medical US @LillyMedical]

Data from a randomized Phase 3 trial highlight the clinical meaningfulness of an amyloid-targeting therapy. Click here to read more: https://t.co/MH48HkF4tq

[Lilly Medical US @LillyMedical]

Thank you to everyone who visited the Lilly Medical team at #EASCongress2026 in Athens. Attendees can revisit data we presented at this congress on the Lilly Science page.

Learn more: https://t.co/cU6LK0As9q

[Lilly Medical US @LillyMedical]

Attending the 2026 #ADASciSessions? Visit Lilly Medical at booth 707 in New Orleans for more on our latest scientific data and planned activities.

Learn more: https://t.co/hKxJTV18JB

[Lilly Medical US @LillyMedical]

New findings from SURMOUNT-MAINTAIN: A Phase 3 study evaluating the maintenance of reduced body weight in adults with obesity or overweight with weight-related comorbidities.

Learn More: https://t.co/ls95JKB6U4

[Lilly Medical US @LillyMedical]

Blood biomarkers (BBMs) are emerging as an additional tool for confirming amyloid pathology in symptomatic individuals. Learn more about the role of BBMs in #Alzheimers disease diagnosis: https://t.co/zIJgsUp6u3

[Lilly Medical US @LillyMedical]

Join the Lilly Medical special session at #EASCongress2026 in Athens on Monday, May 26th. Visit the Lilly Medical booth 07 for more information!

Learn more: https://t.co/O9RhtPhJPB

[Lilly Medical US @LillyMedical]

Results from the TOGETHER-PsO trial investigating the concomitant use of an IL-17A inhibitor and a dual GIP/GLP-1 receptor agonist in adults with moderate-to-severe psoriasis and overweight or obesity are now available.

View related content here: https://t.co/1bV3ixg2G8

[Lilly Medical US @LillyMedical]

Misconceptions about alcohol use disorder (AUD) are common—even in clinical settings. Understanding AUD is often complicated by stigma and common misunderstandings. Explore common AUD misconceptions and see the whole picture of AUD: https://t.co/eKhXX9tPL4

#AlcoholUseDisorder

[Lilly Medical US @LillyMedical]

Attending #EASCongress2026 in Athens? Visit the Lilly Medical team at booth 07, May 24-27, to connect with our medical team. Click below to learn more on the program.

Learn more: https://t.co/C183IMN8ei

[Lilly Medical US @LillyMedical]

New findings from ATTAIN-MAINTAIN: A Phase 3b study examining maintenance of body weight reduction in adults with obesity or overweight with weight-related comorbidities.

Learn More: https://t.co/6xGjmwTi9B

[Lilly Medical US @LillyMedical]

New post-hoc analysis from QWINT-1 examining outcomes across weekly fixed insulin doses in adults with type 2 diabetes.

Learn More: https://t.co/P78ZC8gVXQ

[Lilly Medical US @LillyMedical]

Visit Booth 4019 at #AAPA26 in New Orleans, May 15–19, to learn how to frame your patients’ cognitive health visits with tomorrow in mind and explore Alzheimer’s disease and dementia resources. Learn more at: https://t.co/5yNTigN1GF

[Lilly Medical US @LillyMedical]

Obesity management extends beyond weight alone. This infographic provides insights on addressing obesity alongside psoriasis care, including considerations for assessment and shared ownership across care teams. Click to view the full infographic: https://t.co/RBEescGmZt

[Lilly Medical US @LillyMedical]

Visit Table 6 at #PM2026 in Baltimore, May 14-17, to learn what it means to establish a cognitive health frame of reference for your patients and discover Alzheimer’s disease and dementia resources. Click here to learn more: https://t.co/epuFtFI3iC

[Lilly Medical US @LillyMedical]

Attending EAC 2026? Join our Lilly Symposium: "A Step Forward: Deep & Stable Control in Moderate-to-Severe Atopic Dermatitis" by Dr. Autumn Burnette, MC, FACAAI & Dr. Bob Geng, MD | Thu, May 28 · 2:15 PM ET | The Breakers, Palm Beach, FL. View Agenda: https://t.co/a9cFlVBQMC

[Lilly Medical US @LillyMedical]

Join Lilly Medical special sessions at #ECO2026 in Istanbul on May 13th & 14th, featuring leading experts discussing long-term weight management.

Learn more: https://t.co/ubXBoCwELw

[Lilly Medical US @LillyMedical]

Recent Publication Alert! New ADvocate 1&2 data on an IL-13 inhibitor and the depth of response in moderate-to-severe atopic dermatitis is now available in the Journal of Dermatological Treatment. Click to learn more: https://t.co/mR4bqwsASf

[Lilly Medical US @LillyMedical]

Thank you for joining us at CCR-East! We enjoyed connecting with you in Miramar Beach, Florida. Visit the Lilly Medical congress hub to see the research we presented at this year's meeting: https://t.co/qVXNEn01Wr

[Lilly Medical US @LillyMedical]

Attending ECO 2026 in Istanbul? Visit the Lilly Medical Booth Number 26, May 12-16, to connect with our medical team.

Learn more: https://t.co/KoP6qfPjpc

[Lilly Medical US @LillyMedical]

We enjoyed connecting with you at #DDW2026 in Chicago! Missed our latest GI research? Check out all of Lilly's disclosures from DDW here: https://t.co/HyRlb6Abjn